Jeff Lewis

1.7k total citations
24 papers, 369 citations indexed

About

Jeff Lewis is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jeff Lewis has authored 24 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Jeff Lewis's work include Lung Cancer Treatments and Mutations (11 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Jeff Lewis is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Jeff Lewis collaborates with scholars based in United States, Mexico and Israel. Jeff Lewis's co-authors include John V. Heymach, Stephen G. Swisher, Jack A. Roth, Jianjun Zhang, Waree Rinsurongkawong, J. Jack Lee, Emily Roarty, Vassiliki A. Papadimitrakopoulou, Grant G. Schultz and Marcelo V. Negrão and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Jeff Lewis

22 papers receiving 365 citations

Peers

Countries citing papers authored by Jeff Lewis

Since Specialization

Citations

This map shows the geographic impact of Jeff Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Lewis more than expected).

Fields of papers citing papers by Jeff Lewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Lewis. The network helps show where Jeff Lewis may publish in the future.

Co-authorship network of co-authors of Jeff Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Lewis. A scholar is included among the top collaborators of Jeff Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Lewis. Jeff Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	995MO Association of SARS-COV-2 mRNA vaccines with tumor PD-L1 expression and clinical responses to immune checkpoint blockade 2024 ·Annals of Oncology ·Adam Grippin, (unknown), (unknown), Erin L. Young, (unknown), Ellen T. Chang, Ramez Kouzy, Jeff Lewis, Xiaolin Wei, (unknown), Jih‐Jong Lee, (unknown), (unknown), Hai T. Tran, (unknown), John V. Heymach, J. Zhang, Elias Sayour, Wen Jiang, Steven H. Lin	2
2	MA15.04 Timing of Pre-Biopsy COVID-mRNA Vaccination and PD-L1 Expression in Advanced Non-Small Cell Lung Cancer 2023 ·Journal of Thoracic Oncology ·Adam Grippin, Brian De, Katharina Fink, David A. Swanson, Charles Y.F. Young, Ellen T. Chang, Amber L. Johns, Edward Cha, (unknown), Stephanie O. Dudzinski, Jeff Lewis, (unknown), (unknown), J. Jack Lee, J. Zhang, (unknown), (unknown), John V. Heymach, Steven H. Lin	1
3	Abstract 4264: The genomic landscape of RET fusions in non-small cell lung cancer and the impact of co-occurring genomic alterations on the efficacy of selective RET inhibitors 2023 ·Cancer Research ·(unknown), Simon Heeke, Lei Feng, Leylah Drusbosky, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, J. Jack Lee, Jianjun Zhang, Don L. Gibbons, (unknown), Vincent K. Lam, Vivek Subbiah, John V. Heymach, Yasir Y. Elamin	1
4	Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer 2022 ·Clinical Lung Cancer ·Mehmet Altan, Eric K. Singhi, (unknown), Brett W. Carter, Cheuk Hong Leung, J. Jack Lee, Carolyn J. Presley, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Jianjun Zhang, Don L. Gibbons, Ara A. Vaporciyan, John V. Heymach, Frank E. Mott	9
5	STK11 /LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition 2020 ·Clinical Cancer Research ·Piyada Sitthideatphaiboon, Ana Galan Cobo, Marcelo V. Negrão, Xiao Qu, Alissa Poteete, Fahao Zhang, Diane D. Liu, Whitney E. Lewis, (unknown), Jeff Lewis, Waree Rinsurongkawong, Uma Giri, J. Jack Lee, Jianjun Zhang, Jack A. Roth, Stephen G. Swisher, John V. Heymach	57
6	Risk Factors for and Time to Recurrence of Symptomatic Malignant Pleural Effusion in Patients With Metastatic Non-Small Cell Lung Cancer with EGFR or ALK Mutations 2020 ·CHEST Journal ·(unknown), David E. Ost, (unknown), (unknown), Roberto F. Casal, Carlos A. Jimenez, Georgie A. Eapen, Jeff Lewis, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, J. Jack Lee, Yasir Y. Elamin, Jianjun Zhang, Jack A. Roth, Stephen G. Swisher, John V. Heymach, Horiana B. Grosu	14
7	Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC 2020 ·Journal of Thoracic Oncology ·Vincent K. Lam, Jianjun Zhang, Carol C. Wu, Hai T. Tran, Lerong Li, Lixia Diao, Jing Wang, Waree Rinsurongkawong, Victoria M. Raymond, Richard B. Lanman, Jeff Lewis, Emily Roarty, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, Don L. Gibbons, Vassiliki A. Papadimitrakopoulou, John V. Heymach	58
8	MA19.03 Differences in Symptom Burden Between Responsive and Progressive Disease in Advanced Non-Small Cell Lung Cancer (aNSCLC) 2019 ·Journal of Thoracic Oncology ·Loretta A. Williams, Qiuling Shi, (unknown), (unknown), (unknown), Seyedeh Dibaj, Sheenu Chandwani, Emily Roarty, Waree Rinsurongkawong, Jeff Lewis, Thomas Burke, Charles S. Cleeland, Jes Chauviere Lee, Jack A. Roth, (unknown), John V. Heymach, J. Zhang, George R. Simon	1
9	PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non–Small Cell Lung Cancer 2019 ·Journal of Thoracic Oncology ·Marcelo V. Negrão, Vincent K. Lam, Alexandre Reuben, Maria Laura Rubin, (unknown), Emily Roarty, Waree Rinsurongkawong, Jeff Lewis, Jack A. Roth, Stephen G. Swisher, Don L. Gibbons, Ignacio I. Wistuba, Vassiliki A. Papadimitrakopoulou, Bonnie S. Glisson, George R. Blumenschein, J. Jack Lee, John V. Heymach, Jianjun Zhang	69
10	P3.01-91 Computing the Impact of Immunotherapy on the Non-Small Cell Lung Cancer (NSCLC) Therapeutic Landscape 2018 ·Journal of Thoracic Oncology ·(unknown), Sheenu Chandwani, (unknown), Seyedeh Dibaj, (unknown), Emily Roarty, J. Zhang, (unknown), Jeff Lewis, Jes Chauviere Lee, Jack A. Roth, Stephen G. Swisher, John V. Heymach, Thomas Burke, George R. Simon	1
11	Local Consolidation Therapy (LCT) After First Line Tyrosine Kinase Inhibitor (TKI) for Patients With EGFR Mutant Metastatic Non–small-cell Lung Cancer (NSCLC) 2018 ·Clinical Lung Cancer ·Yasir Y. Elamin, Daniel R. Gomez, Mara B. Antonoff, Jacqulyne Robichaux, Hai T. Tran, (unknown), (unknown), Marcelo V. Negrão, Xiuning Le, (unknown), Jeff Lewis, Lara Lacerda, Emily Roarty, Stephen G. Swisher, Jack A. Roth, Jianjun Zhang, Vassiliki A. Papadimitrakopoulou, John V. Heymach	44
12	MA19.10 Impact of STK11/LKB1 Genomic Alterations on Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC 2018 ·Journal of Thoracic Oncology ·Ferdinandos Skoulidis, Yasir Y. Elamin, Vincent K. Lam, J. Zhang, Jeff Lewis, Waree Rinsurongkawong, (unknown), Jack A. Roth, Stephen G. Swisher, Vassiliki A. Papadimitrakopoulou, John V. Heymach	2
13	Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations 2018 ·Clinical Lung Cancer ·Vincent K. Lam, Hai T. Tran, Kimberly C. Banks, Richard B. Lanman, Waree Rinsurongkawong, Nir Peled, Jeff Lewis, J. Jack Lee, Jack A. Roth, Emily Roarty, Stephen G. Swisher, AmirAli Talasaz, P. Andrew Futreal, Vassiliki A. Papadimitrakopoulou, John V. Heymach, Jianjun Zhang	32
14	MA14.03 The Impact of Genomic Landscape of EGFR Mutant NSCLC on Response to Targeted and Immune Therapy 2017 ·Journal of Thoracic Oncology ·Yasir Y. Elamin, Waree Rinsurongkawong, Hai T. Tran, Kathryn A. Gold, Jeff Lewis, Emily Roarty, P. Andrew Futreal, Jianjun Zhang, John V. Heymach	1
15	MA04.07 Impact of Major Co-Mutations on the Immune Contexture and Response of KRAS-Mutant Lung Adenocarcinoma to Immunotherapy 2017 ·Journal of Thoracic Oncology ·Ferdinandos Skoulidis, Yasir Y. Elamin, Vassiliki A. Papadimitrakopoulou, Pan Tong, Jing Wang, Jeff Lewis, Waree Rinsurongkawong, (unknown), Emily Roarty, Jianjun Zhang, Hai T. Tran, Jaime Rodriguez‐Canales, Edwin R. Parra, Carmen Behrens, Humam Kadara, Ignacio I. Wistuba, John V. Heymach	7
16	Response to single-agent (SA) chemotherapy (CTx) after immunotherapy exposure in non-small cell lung cancer (NSCLC). 2017 ·Journal of Clinical Oncology ·Gustavo Schvartsman, S. Andrew Peng, (unknown), J. Jack Lee, Marcelo F. Benveniste, Jianjun Zhang, Waree Rinsurongkawong, Jeff Lewis, Emily Roarty, Lara Lacerda, Jack A. Roth, Stephen G. Swisher, John V. Heymach, Frank V. Fossella, William Nassib William	2
17	CANCER AND CHRONIC KIDNEY DISEASE: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF 33,618 PARTICIPANTS 2014 ·Oxford University Research Archive (ORA) (University of Oxford) ·(unknown), Natalie Staplin, Jonathan Emberson, Colin Baigent, Richard Turner, (unknown), Sophia Zoungas, Carol A. Pollock, Brian Cooper, David Harris, (unknown), Paul Mitchell, Rebecca M. Prince, Wendy Lim, Jeff Lewis, Chapman, Jonathan C. Craig	3
18	Evaluating the Impact of Raised Median Installations 2007 ·Grant G. Schultz, Jeff Lewis, (unknown)	0
19	Safety Impacts of Access Management Techniques in Utah 2007 ·Transportation Research Record Journal of the Transportation Research Board ·Grant G. Schultz, Jeff Lewis, (unknown)	21
20	Phase-1 trial of ZIO-101, a novel organic arsenic in patients with advanced cancers 2006 ·Journal of Clinical Oncology ·Luis H. Camacho, David S. Hong, Carolina Gutiérrez, (unknown), Nizar M. Tannir, Catriona Parker, Michelle Purdom, Jeff Lewis, (unknown), Razelle Kurzrock	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact